Deaths Due to Covid-19 in Rokan Hulu Regency: Descriptive Epidemiological Studies
Studi Epidemiologi Deskriptif
Introduction: Since COVID-19 emerged in Wuhan and spread to all corners of the world, many deaths have been reported. Some studies say that several comorbidities exacerbate death suffered previously. Research Objectives: To describe the deaths of patients with COVID-19 in Rokan Hulu Regency. Methodology: It is carried out using a quantitative descriptive method by conducting an explorative analysis. The data used are sourced from epidemiological surveillance data from the Rokan Hulu District Health Office. Deaths due to COVID-19 were estimated according to gender, signs and symptoms, comorbidities, and places of care. Results: A total of 356 out of 5319 people (6.69%) died from COVID-19. The highest distribution of deaths in the female sex was 51.97%. Most of the deaths occurred in patients with COVID-19 with several comorbidities such as pneumonia (35.53%), diabetes mellitus (26.40%), hypertension (15.23%), heart disease (14.21%), kidney failure (8.12%), and other diseases ( 36.55%). Of all deaths, 84.83% died in hospital. Conclusion: Most of the deaths from COVID-19 patients in Rokan Hulu Regency occurred in women, had other comorbid illnesses, followed by pneumonia.
Aggarwal, G., Henry, B., Aggarwal, S. & Bangalore, S., 2020. Cardiovascular Safety of Potential Drugs for the Treatment of Coronavirus Disease 2019. American Journal of Cardiology, Volume 128, p. 147 â€“ 150.
Alharbi, Y., Alqahtani, A., Albalawi, O. & Bakouri, M., 2020. Epidemiological Modeling of COVID-19 in Saudi Arabia : Spread Projection, Awareness, and Impact of Treatment. Applied Sciences (Switzerland), Volume 10 (17).
Annisa, D., 2021. InfeksiEmerging. [Online]
[Accessed 8 Desember 2021].
Chan, J. F. W. et al., 2020. A Familial Cluster of Pneumonia Associated with the 2019 Novel Coronavirus Indicating Person-to-Person Transmission: A Study of a Family Cluster. The Lancet, Volume 395 (10223), p. 514 â€“ 523.
Drew, C. & Adisasmita, A. C., 2021. Gejala dan Komorbid yang Memengaruhi Mortalitas Pasien Positif COVID-19 di Jakarta Timur, Maret - September 2020. Tarumanagara Medical Journal, April, Volume 3, No 3, pp. 274 - 283.
Hikmawati, I. & Setiyabudi, R., 2020. Hikmawati, I., Hipertensi Dan Diabetes Militus Sebagai Penyakit Penyerta Utama Covid-19 Di Indonesia Hypertension and Diabetes Mellitus As Covid-19 Comorbidities in Indonesia. s.l., LPPM UMP.
Huang, C. et al., 2020. Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. The Lancet, Volume 395, p. 497 â€“ 506.
Hu, B., Guo, H., Zhou, P. & Shi, Z., 2020. Characteristics of SARS-CoV-2 and COVID-19. Nature Reviews Journals, Volume 19, pp. 141 - 154.
Kemenkes, 2020. Pedoman Pencegahan dan Pengendalian Corona Virus Disease (COVID-19). 5 ed. Jakarta: Kemenkes RI.
Lancet, T., 2020. The Gendered Dimensions of COVID-19. The Lancet, 1168(10231), p. 395.
Longo, D., Fauci, A., Kasper, D. & Hauser, S., 2020. Principles of Internal Medicine. 18 ed. New York: NY: McGraw-Hill.
Mantovani, A., Byrne, C. D., Zheng, M. H. & Targher, G., 2020. Diabetes as a Risk Factor for Greater COVID-19 Severity and in-Hospital Death : A Meta-Analysis of Observational Studies. Nutrition, Metabolism and Cardiovascular Diseases, Volume 30 (8), p. 1236 â€“ 1248.
Masetti, C. et al., 2020. High Mortality in COVID-19 Patients with Mild Respiratory Disease. European Journal of Clinical Investigation , Volume 50 (9), pp. 1 - 6.
Noor, F. & Islam, M., 2020. Prevalence and Associated Risk Factors of Mortality among COVID-19 Patients : A Meta-Analysis. J Community Health, Volume 45 (6), pp. 1270 - 1282.
Onder, G., Rezza, G. & Brusaferro, S., 2020. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. JAMA - Journal of the American Medical Association, Volume 323 (18), p. 1775 â€“ 1776.
Phelps, M. et al., 2021. Cardiovascular Comorbidities as Predictors for Severe COVID-19 Infection or Death. European Heart Journal - Quality of Care and Clinical Outcomes, Volume 7 (2), p. 172 â€“ 180.
Rajunitrigo, Puhilan & Muryanto, I., 2021. Epidemiologi Deskriptif : Kasus Konfirmasi, Kematian dan Testing Covid-19 di Riau. Buletin Epidemiologi, pp. 3 - 7.
Rozaliyani, A. et al., 2020. Rozaliyani, A., Savitri, A. I., Setianingrum, F., Shelly, T. N., Ratnasari, V., Kuswindarti, R., Factors Associated with Death in COVID-19 Patients in Jakarta, Indonesia : An Epidemiological. Acta Medica Indonesiana, Volume 52 (3), pp. 246 - 254.
Satria, R. M. A., Tutupoho, R. V. & Chalidyanto, D., 2020. Analisis faktor Risiko Kematian Dengan Penyakit Komorbid COVID-19. Jurnal Keperawatan Silampari, Desember, Volume 4, No 1, pp. 48 - 55.
Wang, B., Li, R., Lu, Z. & Huang, Y., 2020. Does Comorbidity Increase the Risk of Patients with Covid-19: Evidence from Meta-Analysis. Aging, Volume 12 (7), p. 6049 â€“ 6057.
Wang, D. et al., 2020. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirusâ€“Infected Pneumonia in Wuhan, China. JAMA, 323(11), pp. 1061 - 1069.
Wu, Y., Chen, C. & Chan, Y., 2020. The Outbreak of COVID-19 : An Overview. J Chinese Med Assoc, Volume 83 (3), p. 217 â€“ 220.
Yang, W. & Yan, F., 2020. Patients with RT-PCR-Confirmed COVID-19 and Normal Chest CT. Radiology, Volume 41 (1), p. 43 â€“ 43.
Ye, G. et al., 2020. Clinical Characteristics of Severe Acute Respiratory Syndrome Coronavirus 2 Reactivation. Journal of Infection, 80(5), pp. e14 - e17.
Zhou, F. et al., 2020. Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: a Retrospective Cohort Study. The Lancet, Volume 395, pp. 1054 - 1062.
Zhu, N. et al., 2020. A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine, Volume 382 (8), pp. 727 - 733.
Zuin, M. et al., 2020. Arterial Hypertension and Risk of Death in Patients with COVID-19 Infection : Systematic Review and Meta-Analysis. Journal of Infection, Volume 81 (1), pp. e84 - e86.
How to Cite
Copyright (c) 2021 Jurnal Kesehatan Komunitas
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright @2017. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (http://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted non-commercial used, distribution and reproduction in any medium